UiPath Announces Investments in Saudi Arabia, Including First Saudi School of Automation and New Office Location in Riyadh
CEO Rob Enslin to deliver a keynote address at LEAP 2024 UiPath Business Automation Platform to showcase leading AI and automation innovations in Hall 2A at booth... Read more.
Wolters Kluwer launches CCH iFirm® tax and accounting cloud platform in the U.K.
Continuing its global rollout, the award-winning CCH iFirm is set to transform British tax and accounting practices by improving their efficiency and productivity... Read more.
Axelspace’s Demonstration Satellite “PYXIS” Scheduled for Launch
About the launch and the missions of PYXIS TOKYO–(BUSINESS WIRE)–#axelspace–Axelspace Corporation’s (Axelspace) demonstration satellite PYXIS... Read more.
VeriSilicon’s industry-leading embedded GPU IP powers HPMicro’s high-performance HPM6800 series RISC-V MCU
A new generation of instrumentation dashboard products with high image quality and low power consumption SHANGHAI–(BUSINESS WIRE)–#CameraMonitorSystem–VeriSilicon... Read more.
Europcar Mobility Group Expands in India, With Satguru Travel Becoming Its New Europcar Franchisee
As part of its new strategic framework EXCEED, Europcar Mobility Group reinforces its global footprint thanks to a franchise agreement with Satguru Travel in India,... Read more.
Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer or HR Positive, HER2 Negative Breast Cancer
Parallel applications based on TROPION-Lung01 and TROPION-Breast01 phase 3 trial results demonstrating Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan... Read more.
OpenGate Capital Enters into Exclusive Discussions to Sell SMAC
Consortium of investor and management team to acquire French waterproofing business LOS ANGELES & PARIS–(BUSINESS WIRE)–OpenGate Capital (“OpenGate”),... Read more.
GenSight Biologics Announces LUMEVOQ® Scientific Updates at NANOS 2024
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering... Read more.
BenevolentAI: Notice of Preliminary Results
LONDON–(BUSINESS WIRE)–BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate... Read more.
BenevolentAI: Notice of Preliminary Results
LONDON–(BUSINESS WIRE)–BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate... Read more.